| 000 | 01463 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514023744.0 | ||
| 264 | 0 | _c20020610 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(01)00441-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoumakis, George | |
| 245 | 0 | 0 |
_aIs weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cMar 2002 |
||
| 300 |
_a315-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDemiri, Matina | |
| 700 | 1 | _aBarbounis, Vassilios | |
| 700 | 1 | _aVassilomanolakis, Michail | |
| 700 | 1 | _aGontikakis, Emmanuel | |
| 700 | 1 | _aPamouksoglou, Philip | |
| 700 | 1 | _aDahabre, Jabrahel | |
| 700 | 1 | _aEfremidis, Anna P | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 35 _gno. 3 _gp. 315-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(01)00441-x _zAvailable from publisher's website |
| 999 |
_c11753281 _d11753281 |
||